- "Gemzar costs five times more in New Zealand than in Australia
- Study limited by available information on cancer drug prices.
New Zealanders pay almost five times what Australians do for Eli Lilly & Co.’s Gemzar, used to treat breast, lung, pancreatic and ovarian cancers, according to the study of publicly available pricing information from 18 countries.
In Germany, Merck & Co.’s Intron A for skin and blood cancers costs triple what it does in Greece, the researchers found."
'via Blog this'